Despite growing consumer awareness about preventive healthcare, the global supplements industry continues to struggle with adherence: over 60% of users abandon their regimens within three months, primarily due to unpleasant taste, texture, and overall sensory experience. This “organoleptic barrier” has created a major bottleneck for the nutraceutical market—limiting consumer compliance, slowing category growth, and leaving billions in potential revenue untapped. While pharmaceutical firms have long invested in making medicines more palatable, especially for children, the adult supplement sector has largely neglected sensory design as a core driver of health outcomes.

The R&D Grail: An AI-Led Innovation Programme

To address this gap, Indian researchers have launched The R&D Grail, a global innovation programme spearheaded by NutrifyGenie AI, that applies AI-driven predictive modelling, advanced delivery technologies, and structured R&D pipelines to reinvent how nutritional products are developed. The initiative integrates data science with sensory research to forecast consumer acceptance, accelerate product prototyping, and optimise formulations of plant-based bioactives without compromising efficacy. This approach marks a strategic shift from flavour masking to predictive product engineering, enabling companies to design supplements for both clinical effectiveness and long-term user engagement.

Building a Global R&D Network from India

The R&D Grail will start in India and expand to Southeast Asia, the Middle East, Europe, and North America—where local teams will adapt indigenous herbs and flavour profiles to regional palates. It will roll out virtual global webinars for scientists and R&D professionals alongside hands-on workshops in India for formulators, flavour scientists, and data specialists, creating a distributed innovation network that bridges traditional plant knowledge with modern AI-led design frameworks.

Industry Leaders Back AI-Driven Sensory Innovation

“Most of the industry has relied solely on efficacy and assumed people would simply tolerate the experience,” said Amit Srivastava, Chief Catalyst and Founder of Nutrify Today, which is supporting the initiative. “We are now proving that AI-led sensory innovation can directly drive better adherence—and ultimately, better health outcomes—by making supplements something consumers look forward to using every day.”

Also read: Apollo Hospitals Unveils ‘Athenaa,’ Asia’s First Women-Focused Cancer Care Centre in New Delhi

By embedding sensory experience into the heart of product design, The R&D Grail aims to transform the supplements industry from compliance-driven to experience-driven, while positioning India as a strategic global hub for nutraceutical R&D. As chronic lifestyle-related diseases rise and preventive care becomes a priority, this model could reshape how health products are conceived, developed, and adopted worldwide.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!